Patent ID: 11931367
Assignee: nan
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  G | IPC A  G

Claim 29:
30. The method of claim 22, wherein if said androst-4-en-17β-ol-3-one serum concentration level exceeds a predetermined level, said at least one dose of said maintenance dosage is decreased by from about 76 mg of equivalent amount of androst-4-en-17β-ol-3-one to about 0.5 times at least one previously administered dose, and wherein if said androst-4-en-17β-ol-3-one serum concentration level subceeds a predetermined level, said at least one dose of said maintenance dosage is increased by from about 76 mg of equivalent amount of androst-4-en-17β-ol-3-one to about 2.0 times at least one previously administered dose, and wherein if said androst-4-en-17β-ol-3-one serum concentration level is within a predetermined range, said at least one dose of said maintenance dosage is not increased or decreased relative to at least one previously administered dose.